Navigation Links
Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
Date:3/28/2008

- Company Plans to Request Timely Hearing before a NASDAQ Listing

Qualifications Panel -

FREMONT, Calif., March 28 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML, VRMLD) (the "Company"), a molecular diagnostics company, announced today that on March 18, 2008, the Company received communication from The NASDAQ Stock Market ("NASDAQ") that, as a result of the Company's common stock closing at $1.00 per share or more for a minimum of 10 consecutive business days, it has achieved compliance with the minimum bid price requirement for continued listing set forth in NASDAQ Marketplace Rule 4310(c)(4) ("Rule 4310(c)(4)").

The communication follows a notice of noncompliance from NASDAQ dated September 6, 2007, which was disclosed by the Company on September 7, 2007, that indicated that the Company failed to comply with the minimum bid price requirement for continued listing set forth in Rule 4310(c)(4). The notice of noncompliance gave the Company notice that the bid price of its common stock had closed under $1.00 per share for the previous 30 business days, and stated that if the Company could not demonstrate compliance with Rule 4310(c)(4) by March 4, 2008, the NASDAQ staff would determine whether or not the Company meets The NASDAQ Capital Market initial listing criteria set forth in NASDAQ Marketplace Rule 4310(c), except for the bid price requirement.

The bid price requirement was met in part as a result of the 1-for-10 reverse stock split of the Company's outstanding common stock effected by the filing of the Company's Third Amended and Restated Certificate of Incorporation on February 29, 2008, which was disclosed by the Company on March 3, 2008. The reverse stock split was effec
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. World Think Tank on Type 1 Diabetes Meets in Miami
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Franz ... technology, today announced that its flagship product, AllegroGraph, has ... Graph Database Market Update report. AllegroGraph is ... leveraging the W3C industry standards. Graph databases are skyrocketing in ... years, according to a recent DBMS ranking by ...
(Date:5/5/2015)... 2015  Orexigen Therapeutics, Inc. (Nasdaq: OREX ) ... on Friday, May 8 before the market opens. The ... conference call at 8:30 a.m. Eastern Time (5:30 a.m. ... accessed by phone by calling (800) 708-4540 (domestic) or ... be accessed live on the Investors section of the ...
(Date:5/5/2015)... May 5, 2015  Indianapolis-based medical device manufacturer ... innovative line of products including the BrainPath® and ... accessing deep-seated brain abnormalities and then removing affected ... at more than 50 institutions throughout ... also been included in 12 abstracts, three peer-reviewed ...
(Date:5/4/2015)... May 4, 2015 Tobira Therapeutics, Inc. ... the development and commercialization of novel treatments for ... of its merger with Regado Biosciences, Inc. (NASDAQ: ... closing of the merger, Tobira raised $40 million ... investors and all current Tobira institutional investors, including ...
Breaking Biology Technology:Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 2Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 5Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 6
... CPHD ) today announced preliminary revenue results ... 31, 2008. , Based on ... quarter of 2008 is expected to be approximately $38 ... Total revenue for the,full year ended December 31, 2008 ...
... industry creates growth opportunities for healthcare and life ... The credit crisis and the global economy meltdown ... Healthcare industry in 2009. Healthcare in Asia Pacific ... developed countries.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )Dr. Louis Payet, Senior ...
... Group, Inc. released TreatmentTrends(TM): US Nephrology, a ... Nephrologists in the US. The renal anemia market ... percent of patients with Chronic Kidney Disease not on ... same period last year, only a small percent of ...
Cached Biology Technology:Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results 2Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results 3Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results 4Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results 52009 is Healthy for Asia 22009 is Healthy for Asia 3BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/26/2015)... , March 26, 2015 The ... social, recreation and athletic club, today announced it has ... allow freedom of movement for members and staff, while ... a comprehensive process, we selected FST,s IMID Access system ... convenience for our members and staff, in addition to ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... three days and are simultaneously infected with malaria, no ... averted. In addition, the animals treated in this manner ... discovery was made by the team headed by Dr. ... Heidelberg University Hospital in cooperation with Dr. Kai Matuschewski ...
... Several LSU researchers have been awarded Rapid Response Grants ... variety of pathways in which the oil spill might impact ... the Louisiana wetlands and Gulf of Mexico region., "Our researchers ... yet ongoing oil spill quite seriously," said Doris Carver, interim ...
... and roads really curb carbon emissions and combat global climate ... a new study by researchers at Lawrence Berkeley National Laboratory ... study the question has found that implementing cool roofs and ... help cities stay cooler, they can also cool the world, ...
Cached Biology News:Antibiotics for the prevention of malaria 2Antibiotics for the prevention of malaria 3LSU researchers secure NSF rapid response grants to study impact of oil spill 2Global model confirms: Cool roofs can offset carbon dioxide emissions and mitigate global warming 2Global model confirms: Cool roofs can offset carbon dioxide emissions and mitigate global warming 3Global model confirms: Cool roofs can offset carbon dioxide emissions and mitigate global warming 4Global model confirms: Cool roofs can offset carbon dioxide emissions and mitigate global warming 5
Ubiquitin Related I Sampler Kit 10 mu g each...
DNA Repair Sampler Kit 10g each...
PKC Sampler Kit 10 mu g each...
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Biology Products: